1887

Abstract

We studied 137 uropathogenic (UPEC) isolates from hospitalized adult patients (Queensland, Australia) for their resistance to 17 antimicrobial agents using the calibrated dichotomous sensitivity method and the presence of class I, II and III integron-associated integrase () genes, including functional class II , as well as the presence of , and genes, using PCR. Randomly amplified polymorphic DNA PCR, a high-resolution biochemical-fingerprinting method (PhP) and phylogenetic grouping were also used to identify the clonality of the sulphonamide-resistant isolates. One hundred and twenty (87.6 %) isolates were resistant to one or more of the tested antimicrobial drugs, with the highest resistance (70.1 %) observed against sulphafurazole (96 isolates). Of these, 84 (87.5 %) contained one or more alleles, with being the most common allele [occurring in 69 (72 %) isolates]. Only 38 of 69 (55.1 %) strains carrying the gene were positive for class I integrase. Our results indicate a high prevalence of sulphafurazole-resistant UPEC strains belonging to different clones among patients with urinary tract infection in Queensland, Australia. We also conclude that these strains carry predominantly a gene that is not commonly associated with the presence of class I integrase, indicating that it may be carried on either a bacterial chromosome or other genetic elements.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.034140-0
2011-11-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/11/1633.html?itemId=/content/journal/jmm/10.1099/jmm.0.034140-0&mimeType=html&fmt=ahah

References

  1. Ang E. L., Obbard J. P., Zhao H. 2009; Directed evolution of aniline dioxygenase for enhanced bioremediation of aromatic amines. Appl Microbiol Biotechnol 81:1063–1070 [View Article][PubMed]
    [Google Scholar]
  2. Antunes P., Machado J., Peixe L. 2007; Dissemination of sul3-containing elements linked to class 1 integrons with an unusual 3′ conserved sequence region among Salmonella isolates. Antimicrob Agents Chemother 51:1545–1548 [View Article][PubMed]
    [Google Scholar]
  3. Barlow R. S., Gobius K. S. 2006; Diverse class 2 integrons in bacteria from beef cattle sources. J Antimicrob Chemother 58:1133–1138 [View Article][PubMed]
    [Google Scholar]
  4. Bartoloni A., Bartalesi F., Mantella A., Dell’Amico E., Roselli M., Strohmeyer M., Barahona H. G., Barrón V. P., Paradisi F., Rossolini G. M. 2004; High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption. J Infect Dis 189:1291–1294 [View Article][PubMed]
    [Google Scholar]
  5. Bean D. C., Livermore D. M., Papa I., Hall L. M. C. 2005; Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. J Antimicrob Chemother 56:962–964 [View Article][PubMed]
    [Google Scholar]
  6. Bell S. M., Gatus B. J., Pham J. N., Rafferty D. L. 2006; Antibiotic Susceptibility Testing by the CDS Method: a Manual for Medical and Veterinary Laboratories 2006, 4th edn.. http://web.med.unsw.edu.au/pathology-cds/CDS2006/CDSBOOK2.pdf
  7. Blahna M. T., Zalewski C. A., Reuer J., Kahlmeter G., Foxman B., Marrs C. F. 2006; The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. J Antimicrob Chemother 57:666–672 [View Article][PubMed]
    [Google Scholar]
  8. Castro G. R., Larson B. K., Panilaitis B., Kaplan D. L. 2005; Emulsan quantitation by Nile red quenching fluorescence assay. Appl Microbiol Biotechnol 67:767–770 [View Article][PubMed]
    [Google Scholar]
  9. Chang L. L., Chang T. M., Chang C. Y. 2007; Variable gene cassette patterns of class 1 integron-associated drug-resistant Escherichia coli in Taiwan. Kaohsiung J Med Sci 23:273–280 [View Article][PubMed]
    [Google Scholar]
  10. Chang C.-Y., Lu P.-L., Lin C.-C., Lee T.-M., Tsai M.-Y., Chang L.-L. 2011; Integron types, gene cassettes, antimicrobial resistance genes and plasmids of Shigella sonnei isolates from outbreaks and sporadic cases in Taiwan. J Med Microbiol 60:197–204 [View Article][PubMed]
    [Google Scholar]
  11. Chen J., Griffiths M. W. 1998; PCR differentiation of Escherichia coli from other gram-negative bacteria using primers derived from the nucleotide sequences flanking the gene encoding the universal stress protein. Lett Appl Microbiol 27:369–371 [View Article][PubMed]
    [Google Scholar]
  12. Clermont O., Bonacorsi S., Bingen E. 2000; Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555–4558 [View Article][PubMed]
    [Google Scholar]
  13. Collis C. M., Kim M.-J., Partridge S. R., Stokes H. W., Hall R. M. 2002; Characterization of the class 3 integron and the site-specific recombination system it determines. J Bacteriol 184:3017–3026 [View Article][PubMed]
    [Google Scholar]
  14. Croxen M. A., Finlay B. B. 2010; Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 8:26–38[PubMed]
    [Google Scholar]
  15. Dillon B., Thomas L., Mohmand G., Zelynski A., Iredell J. 2005; Multiplex PCR for screening of integrons in bacterial lysates. J Microbiol Methods 62:221–232 [View Article][PubMed]
    [Google Scholar]
  16. Farshad S., Japoni A., Hosseini M. 2008; Low distribution of integrons among multidrug resistant E. coli strains isolated from children with community-acquired urinary tract infections in Shiraz, Iran. Pol J Microbiol 57:193–198[PubMed]
    [Google Scholar]
  17. Fierer J., Guiney D. 1999; Extended-spectrum β-lactamases: a plague of plasmids. JAMA 281:563–564 [View Article][PubMed]
    [Google Scholar]
  18. Foxman B., Brown P. 2003; Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 17:227–248 [View Article][PubMed]
    [Google Scholar]
  19. Frank T., Gautier V., Talarmin A., Bercion R., Arlet G. 2007; Characterization of sulphonamide resistance genes and class 1 integron gene cassettes in Enterobacteriaceae, Central African Republic (CAR). J Antimicrob Chemother 59:742–745 [View Article][PubMed]
    [Google Scholar]
  20. Grape M., Sundström L., Kronvall G. 2003; Sulphonamide resistance gene sul3 found in Escherichia coli isolates from human sources. J Antimicrob Chemother 52:1022–1024 [View Article][PubMed]
    [Google Scholar]
  21. Grape M., Farra A., Kronvall G., Sundström L. 2005; Integrons and gene cassettes in clinical isolates of co-trimoxazole-resistant Gram-negative bacteria. Clin Microbiol Infect 11:185–192 [View Article][PubMed]
    [Google Scholar]
  22. Gupta K., Hooton T. M., Stamm W. E. 2001; Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 135:41–50[PubMed] [CrossRef]
    [Google Scholar]
  23. Hall R. M., Collis C. M. 1998; Antibiotic resistance in gram-negative bacteria: the role of gene cassettes and integrons. Drug Resist Updat 1:109–119 [View Article][PubMed]
    [Google Scholar]
  24. Hammerum A. M., Sandvang D., Andersen S. R., Seyfarth A. M., Porsbo L. J., Frimodt-Møller N., Heuer O. E. 2006; Detection of sul1, sul2 and sul3 in sulphonamide resistant Escherichia coli isolates obtained from healthy humans, pork and pigs in Denmark. Int J Food Microbiol 106:235–237 [View Article][PubMed]
    [Google Scholar]
  25. Hansson K., Sundström L., Pelletier A., Roy P. H. 2002; IntI2 integron integrase in Tn7 . J Bacteriol 184:1712–1721 [View Article][PubMed]
    [Google Scholar]
  26. Ho P. L., Wong R. C., Chow K. H., Que T. L. 2009; Distribution of integron-associated trimethoprim-sulfamethoxazole resistance determinants among Escherichia coli from humans and food-producing animals. Lett Appl Microbiol 49:627–634 [View Article][PubMed]
    [Google Scholar]
  27. Huovinen P., Sundström L., Swedberg G., Sköld O. 1995; Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother 39:279–289[PubMed] [CrossRef]
    [Google Scholar]
  28. Infante B., Grape M., Larsson M., Kristiansson C., Pallecchi L., Rossolini G. M., Kronvall G. 2005; Acquired sulphonamide resistance genes in faecal Escherichia coli from healthy children in Bolivia and Peru. Int J Antimicrob Agents 25:308–312 [View Article][PubMed]
    [Google Scholar]
  29. Kaper J. B., Nataro J. P., Mobley H. L. T. 2004; Pathogenic Escherichia coli . Nat Rev Microbiol 2:123–140 [View Article][PubMed]
    [Google Scholar]
  30. Kerrn M. B., Klemmensen T., Frimodt-Møller N., Espersen F. 2002; Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance. J Antimicrob Chemother 50:513–516 [View Article][PubMed]
    [Google Scholar]
  31. Landgren M., Odén H., Kühn I., Osterlund A., Kahlmeter G. 2005; Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries. J Antimicrob Chemother 55:928–937 [View Article][PubMed]
    [Google Scholar]
  32. Leverstein-van Hall M. A., Paauw A., Box A. T. A., Blok H. E. M., Verhoef J., Fluit A. C. 2002; Presence of integron-associated resistance in the community is widespread and contributes to multidrug resistance in the hospital. J Clin Microbiol 40:3038–3040 [View Article][PubMed]
    [Google Scholar]
  33. Leverstein-van Hall M. A., Blok H. E. M., Donders A. R. T., Paauw A., Fluit A. C., Verhoef J. 2003; Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin. J Infect Dis 187:251–259 [View Article][PubMed]
    [Google Scholar]
  34. Long Y. B., Faoagali J., Bodman J., George N., McKay D., Katouli M. 2009; Persistence of multiple antibiotic resistant strains of Acinetobacter baumannii carrying class 1 integron in a hospital setting. Microb Drug Resist 15:167–172 [View Article][PubMed]
    [Google Scholar]
  35. Mabbett A. N., Ulett G. C., Watts R. E., Tree J. J., Totsika M., Ong C. L., Wood J. M., Monaghan W., Looke D. F., Nimmo G. 2009; Virulence properties of asymptomatic bacteriuria Escherichia coli . Int J Med Microbiol 299:53–63 [View Article][PubMed]
    [Google Scholar]
  36. Márquez C., Labbate M., Ingold A. J., Chowdhury P. R., Ramírez M. S., Centrón D., Borthagaray G., Stokes H. W. 2008a; Recovery of a functional class 2 integron from an Escherichia coli strain mediating a urinary tract infection. Antimicrob Agents Chemother 52:4153–4154 [View Article][PubMed]
    [Google Scholar]
  37. Márquez C., Labbate M., Raymondo C., Fernández J., Gestal A. M., Holley M., Borthagaray G., Stokes H. W. 2008b; Urinary tract infections in a South American population: dynamic spread of class 1 integrons and multidrug resistance by homologous and site-specific recombination. J Clin Microbiol 46:3417–3425 [View Article][PubMed]
    [Google Scholar]
  38. Mathai E., Grape M., Kronvall G. 2004; Integrons and multidrug resistance among Escherichia coli causing community-acquired urinary tract infection in southern India. APMIS 112:159–164 [View Article][PubMed]
    [Google Scholar]
  39. Mazel D. 2006; Integrons: agents of bacterial evolution. Nat Rev Microbiol 4:608–620 [View Article][PubMed]
    [Google Scholar]
  40. Moritz E. M., Hergenrother P. J. 2006; The prevalence of plasmids and other mobile genetic elements in clinically important drug-resistant bacteria. In Antimicrobial Resistance in Bacteria pp. 25–54 Edited by Amabile-Cuevas C. F. Wymondham, UK: Horizon Bioscience;
    [Google Scholar]
  41. Nicolle L. E. 2002; Epidemiology of urinary tract infection. Clin Microbiol Newsl 24:135–140 [View Article]
    [Google Scholar]
  42. Nield B. S., Holmes A. J., Gillings M. R., Recchia G. D., Mabbutt B. C., Nevalainen K. M. H., Stokes H. W. 2001; Recovery of new integron classes from environmental DNA. FEMS Microbiol Lett 195:59–65 [View Article][PubMed]
    [Google Scholar]
  43. Ramos N. L., Saayman M. L., Chapman T. A., Tucker J. R., Smith H. V., Faoagali J., Chin J. C., Brauner A., Katouli M. 2010; Genetic relatedness and virulence gene profiles of Escherichia coli strains isolated from septicaemic and uroseptic patients. Eur J Clin Microbiol Infect Dis 29:15–23 [View Article][PubMed]
    [Google Scholar]
  44. Rao A. N., Barlow M., Clark L. A., Boring J. R. III, Tenover F. C., McGowan J. E. Jr 2006; Class 1 integrons in resistant Escherichia coli and Klebsiella spp., US hospitals. Emerg Infect Dis 12:1011–1014[PubMed] [CrossRef]
    [Google Scholar]
  45. Rijavec M., Erjavec M. S., Avgustin J. A., Reissbrodt R., Fruth A., Krizan-Hergouth V., Zgur-Bertok D. 2006; High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups. Curr Microbiol 53:158–162 [View Article][PubMed]
    [Google Scholar]
  46. Rowe-Magnus D. A., Mazel D. 2002; The role of integrons in antibiotic resistance gene capture. Int J Med Microbiol 292:115–125 [View Article][PubMed]
    [Google Scholar]
  47. Russo T. A., Johnson J. R. 2003; Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 5:449–456 [View Article][PubMed]
    [Google Scholar]
  48. Saeedi B., Tärnberg M., Gill H., Hällgren A., Jonasson J., Nilsson L. E., Isaksson B., Kühn I., Hanberger H. 2005; Phene Plate (PhP) biochemical fingerprinting. A screening method for epidemiological typing of enterococcal isolates. APMIS 113:603–612 [View Article][PubMed]
    [Google Scholar]
  49. Sköld O. 2000; Sulfonamide resistance: mechanisms and trends. Drug Resist Updat 3:155–160 [View Article][PubMed]
    [Google Scholar]
  50. Sneath P. H. A., Sokal R. R. 1973 Numerical Taxonomy: the Principles and Practice of Numerical Classification San Francisco: W. H. Freeman;
    [Google Scholar]
  51. Solberg O. D., Ajiboye R. M., Riley L. W. 2006; Origin of class 1 and 2 integrons and gene cassettes in a population-based sample of uropathogenic Escherichia coli . J Clin Microbiol 44:1347–1351 [View Article][PubMed]
    [Google Scholar]
  52. Tartof S. Y., Solberg O. D., Riley L. W. 2007; Genotypic analyses of uropathogenic Escherichia coli based on fimH single nucleotide polymorphisms (SNPs). J Med Microbiol 56:1363–1369 [View Article][PubMed]
    [Google Scholar]
  53. Trobos M., Christensen H., Sunde M., Nordentoft S., Agersø Y., Simonsen G. S., Hammerum A. M., Olsen J. E. 2009; Characterization of sulphonamide-resistant Escherichia coli using comparison of sul2 gene sequences and multilocus sequence typing. Microbiology 155:831–836 [View Article][PubMed]
    [Google Scholar]
  54. van Treeck U., Schmidt F., Wiedemann B. 1981; Molecular nature of a streptomycin and sulfonamide resistance plasmid (pBP1) prevalent in clinical Escherichia coli strains and integration of an ampicillin resistance transposon (TnA). Antimicrob Agents Chemother 19:371–380[PubMed] [CrossRef]
    [Google Scholar]
  55. Warren J. W., Abrutyn E., Hebel J. R., Johnson J. R., Schaeffer A. J., Stamm W. E. Infectious Diseases Society of America (IDSA) 1999; Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 29:745–758 [View Article][PubMed]
    [Google Scholar]
  56. Wirth T., Falush D., Lan R., Colles F., Mensa P., Wieler L. H., Karch H., Reeves P. R., Maiden M. C. J. et al. 2006; Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60:1136–1151 [View Article][PubMed]
    [Google Scholar]
  57. Wu S., Dalsgaard A., Hammerum A. M., Porsbo L. J., Jensen L. B. 2010; Prevalence and characterization of plasmids carrying sulfonamide resistance genes among Escherichia coli from pigs, pig carcasses and human. Acta Vet Scand 52:47 [View Article][PubMed]
    [Google Scholar]
  58. Yu H. S., Lee J. C., Kang H. Y., Ro D. W., Chung J. Y., Jeong Y. S., Tae S. H., Choi C. H., Lee E. Y. et al. 2003; Changes in gene cassettes of class 1 integrons among Escherichia coli isolates from urine specimens collected in Korea during the last two decades. J Clin Microbiol 41:5429–5433 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.034140-0
Loading
/content/journal/jmm/10.1099/jmm.0.034140-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error